Search results for "LNC"

showing 10 items of 49 documents

Steroid-growth factor interaction in human prostate cancer. 2. Effects of transforming growth factors on androgen metabolism of prostate cancer cells

1996

The ability of human prostate cancer cells to metabolize androgens was assessed through administration of physiological concentration (0.5-10 nM) of tritiated testosterone (T) as precursor and one-step analysis of both T degradation and products' formation by reverse-phase HPLC and on-line radioactive detection after either 24 h or 72 h incubation. Overall, different prostate cancer cells degraded T quite differently, favoring alternatively reductive or oxidative metabolic pathways. In particular, both LNCaP and DU145 cells retained high levels of unconverted T, with a limited production of androstenedione and its 17-keto derivatives and relatively high amounts of dihydrotestosterone (DHT) …

Malemedicine.medical_specialtymedicine.drug_classClinical BiochemistryBiologyurologic and male genital diseasesBiochemistrychemistry.chemical_compoundEndocrinologyDU145Transforming Growth Factor betaInternal medicineLNCaPTumor Cells CulturedmedicineHumansMolecular BiologyTestosteronePharmacologyAndrosteroneOrganic ChemistryProstatic NeoplasmsTransforming Growth Factor alphaAndrogenEndocrinologychemistryDihydrotestosteroneCancer cellAndrogensmedicine.drugTransforming growth factorSteroids
researchProduct

Upconversion Nanocarriers Encapsulated with Photoactivatable Ru Complexes for Near-Infrared Light-Regulated Enzyme Activity.

2017

Enzyme activity is important for metabolism, cell functions, and treating diseases. However, remote control of enzyme activity in deep tissue remains a challenge. This study demonstrates near-infrared (NIR) light-regulated enzyme activity in living cells based on upconverting nanoparticles (UCNPs) and a photoactivatable Ru complex. The Ru complex is a caged enzyme inhibitor that can be activated by blue light. To prepare a nanocarrier for NIR photoinhibition of enzyme activity, a UCNP and the caged enzyme inhibitors are encapsulated in a hollow mesoporous silica nanoparticle. In such a nanocarrier, the UCNP can harvest NIR light and convert it into blue light, which can activate the caged e…

Materials scienceCell SurvivalInfrared RaysCathepsin KNanoparticle02 engineering and technology010402 general chemistryPhotochemistry01 natural sciencesRutheniumBiomaterialsCell Line TumorLNCaPHumansGeneral Materials ScienceEnzyme Inhibitorsneoplasmschemistry.chemical_classificationbiologytechnology industry and agricultureGeneral ChemistryMesoporous silicaequipment and supplies021001 nanoscience & nanotechnologyPhoton upconversionEnzyme assay0104 chemical sciencesEnzymechemistryEnzyme inhibitorbiology.proteinNanoparticlesNanocarriers0210 nano-technologyBiotechnologySmall (Weinheim an der Bergstrasse, Germany)
researchProduct

Anti-proliferative and pro-apoptotic activities of hydroxytyrosol on different tumour cells: the role of extracellular production of hydrogen peroxide

2011

Several recently published data suggest that the anti-proliferative and pro-apoptotic properties of hydroxytyrosol [3,4-dihydroxyphenyl ethanol (3,4-DHPEA)] on HL60 cells may be mediated by the accumulation of hydrogen peroxide (H2O2) in the culture medium. The aim of this study was to clarify the role played by H2O2 in the chemopreventive activities of 3,4-DHPEA on breast (MDA and MCF-7), prostate (LNCap and PC3) and colon (SW480 and HCT116) cancer cell lines and to investigate the effects of cell culture medium components and the possible mechanisms at the basis of the H2O2-producing properties of 3,4-DHPEA. The proliferation was measured by the MTT assay and the apoptosis by both fluores…

Medicine (miscellaneous)ApoptosisAntioxidantsCulture Media Serum-FreeSuperoxide dismutaseInhibitory Concentration 50chemistry.chemical_compoundCell Line TumorNeoplasmsPyruvic AcidLNCaPExtracellularHumansMTT assayHydroxytyrosolTumour cellsHydrogen peroxideCell ProliferationNutrition and DieteticsbiologyApoptosiOlive oil Tumour cellsHydrogen-Ion ConcentrationPhenylethyl AlcoholOxidantsHydrogen peroxideAntineoplastic Agents PhytogenicOxygenKineticsHydroxytyrosol; Apoptosis; Hydrogen peroxide; Olive oil; Tumour cellsBiochemistrychemistryDrug Resistance NeoplasmCell cultureCatalaseCulture Media Conditionedbiology.proteinSettore BIO/14 - FarmacologiaHydroxytyrosolOxidoreductasesOxidation-ReductionOlive oil
researchProduct

The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: Screening issue and future perspectives

2019

In recent decades, non-alcoholic fatty liver disease (NAFLD) has become the most common liver disease in the Western world, and the occurrence of its complications, such as hepatocellular carcinoma (HCC), has rapidly increased. Obesity and diabetes are considered not only the main triggers for the development of the disease, but also two independent risk factors for HCC. Single nucleotide polymorphisms (such as PNPLA3, TM6SF2 and MBOAT7) are related to the susceptibility to the development of HCC and its progression. Therefore, an appropriate follow-up of these patients is needed for the early diagnosis and treatment of HCC. To date, international guidelines recommend the use of ultrasonogr…

OncologyHepatocellular carcinomaDiseaseReviewlcsh:ChemistryLiver disease0302 clinical medicineDisease ScreeningRisk FactorsMass ScreeningHCClcsh:QH301-705.5SpectroscopyFatty liverLiver NeoplasmsGeneral MedicineComputer Science Applications030220 oncology & carcinogenesisHepatocellular carcinoma030211 gastroenterology & hepatologyMiRNAmedicine.medical_specialtyMicro RNACarcinoma HepatocellularSingle-nucleotide polymorphismCatalysisTM6SF2Inorganic ChemistryDiabetes Complications03 medical and health sciencesDiabetes mellitusInternal medicineNAFLDmedicineAnimalsHumansObesityPhysical and Theoretical ChemistryMolecular BiologyPNPLA3Long non-conding RNAbusiness.industryOrganic Chemistrymedicine.diseasedigestive system diseasesLncRNAlcsh:Biology (General)lcsh:QD1-999businessTM6SF2Non-alcoholic fatty liver disease
researchProduct

Clinical Translation and First In-Human Use of [44Sc]Sc-PSMA-617 for PET Imaging of Metastasized Castrate-Resistant Prostate Cancer

2017

Background: Various trivalent radiometals are well suited for labeling of DOTA-conjugated variants of Glu-ureido-based prostate-specific membrane antigen (PSMA) inhibitors. The DOTA-conjugate PSMA-617 has proven high potential in PSMA radioligand therapy (PSMA-RLT) of prostate cancer as well as PET imaging when labeled with lutetium-177 and gallium-68 respectively. Considering the relatively short physical half-life of gallium-68 this positron emitter precludes prolonged acquisition periods, as required for pre-therapeutic dosimetry or intraoperative applications. In this context, the positron emitter scandium-44 is an attractive alternative for PET imaging. We report the synthesis of [44Sc…

OncologyMalemedicine.medical_specialtytheranostics.Medicine (miscellaneous)Context (language use)SpleenGallium RadioisotopesLutetiumurologic and male genital diseases030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancerHeterocyclic Compounds 1-Ring0302 clinical medicineInternal medicinePositron Emission Tomography Computed TomographyLNCaPmedicineDosimetryHumansRadiometryPharmacology Toxicology and Pharmaceutics (miscellaneous)AgedRadioisotopesUrinary bladderChemistrybusiness.industryDipeptidesProstate-Specific Antigenmedicine.diseaseprostate cancerPSMA-617scandium-44Small intestineProstatic Neoplasms Castration-Resistantmedicine.anatomical_structurePET030220 oncology & carcinogenesisAbsorbed doseRadiopharmaceuticalsNuclear medicinebusinessScandiumResearch PaperHalf-LifeTheranostics
researchProduct

2015

Myoglobin (MB) is not only strongly expressed in myocytes, but also at much lower levels in different cancer entities. 40% of breast tumors are MB-positive, with the globin being co-expressed with markers of tumor hypoxia in a proportion of cases. In breast cancer, MB expression is associated with a positive hormone receptor status and patient prognosis. In prostate cancer, another hormone-dependent cancer type, 53% of tumors were recently shown to express MB. Especially in more aggressive prostate cancer specimen MB expression also correlates with increased patient survival rates. Both findings might be due to tumor-suppressing properties of MB in cancer cells. In contrast to muscle, MB tr…

PCA3Regulation of gene expressionProstate cancerMultidisciplinaryBreast cancerLNCaPCancer cellDNA methylationmedicineChromoplexyBiologymedicine.diseaseMolecular biologyPLOS ONE
researchProduct

Electrode–Electrolyte Compatibility in Solid-Oxide Fuel Cells: Investigation of the LSM–LNC Interface with X-ray Microspectroscopy

2015

Ca:LaNbO4 (LNC) constitutes the last real breakthrough in high-temperature proton conductors, with better chemical and mechanical stability with respect to cerate and zirconate perovskites. However, the low amount of bivalent dopant that can be hosted in the LaNbO4 matrix poses a limit to the proton concentration in the electrolyte. Using synchrotron X-ray microspectroscopy, we investigated the compatibility of annealed LNC/LSM electrolyte/cathode bilayers for proton-conducting SOFCs. The element maps are complemented by microEXAFS and microXANES, giving information on the fate of different cations after diffusion. The X-ray microspectroscopy approach described here is applied for the first…

PROTON CONDUCTORScathodeMaterials scienceGeneral Chemical EngineeringX-ray microspectroscopyXRFOxideelectrolyteElectrolytefuel cellchemistry.chemical_compoundMaterials ChemistrySOFCX-rayCompatibility (geochemistry)General Chemistryelectrodelanthanum manganitelanthanum strontium manganiteEXAFSCHEMICAL COMPATIBILITYchemistryChemical engineeringElectrodemicroXRFFuel cellsLNClanthanum niobateChemistry of Materials
researchProduct

Multilabel segmentation of cancer cell culture on vascular structures with deep neural networks

2020

New increasingly complex in vitro cancer cell models are being developed. These new models seem to represent the cell behavior in vivo more accurately and have better physiological relevance than prior models. An efficient testing method for selecting the most optimal drug treatment does not exist to date. One proposed solution to the problem involves isolation of cancer cells from the patients' cancer tissue, after which they are exposed to potential drugs alone or in combinations to find the most optimal medication. To achieve this goal, methods that can efficiently quantify and analyze changes in tested cell are needed. Our study aimed to detect and segment cells and structures from canc…

Paperneural networkImage Processing3122 CancersComputational biologyneuroverkotmikroskopia030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineIn vivoLNCaPmedicinecancerRadiology Nuclear Medicine and imagingSegmentationErrataContextual image classificationbusiness.industrysegmentationCancerin vitroImage segmentationmedicine.diseasesoluviljelysegmentointisyöpäsolutkuvantaminenin vitro -menetelmäCell culture030220 oncology & carcinogenesisCancer cellmicroscopy3111 Biomedicinebusiness
researchProduct

Molecular Profiling of Potential Human Prostate Cancer Stem Cells

2013

We have investigated the expression of Oct-4, Suz-12, and Cripto-1, as presumptive “stemness” genes, and of connexin 43 (Cx43), Cx32 and androgen receptor (AR), as cell differentiation genes, in two human prostate cancer cell lines, PC3 and LNCaP. This aiming to define molecular profiles of prostate cancer stem cells for a better understanding of prostate carcinogenesis and tumor progression, as well as for prognostic or therapeutic purposes. Cells were grown in 3-dimensional (3D) cell cultures to favor clonal expansion of cancer stem and early progenitor cells, and compared to cells grown in 2-dimensional (2D) cell cultures. Under 3D culture conditions, LNCaP cells and PC3 cells generated …

Pathologymedicine.medical_specialtyCellular differentiationBiologymedicine.diseaseProstate cancerTumor progressionCancer stem cellCell cultureLNCaPmedicineCancer researchStem cellProgenitor cellJournal of Stem Cell Research & Therapy
researchProduct

Synthesis, Labeling and Preclinical Evaluation of a Squaric Acid Containing PSMA Inhibitor Labeled with 68 Ga: A Comparison with PSMA‐11 and PSMA‐617

2020

The L-lysine urea-L-glutamate (KuE) represents a key motif in recent diagnostic and therapeutic radiopharmaceuticals targeting the prostate specific membrane antigen (PSMA). Using a squaric acid moiety for coupling of KuE with a radioactive label, the squaric acid as a linker in the PSMA ligand seems to mimic the aromatic structure of the naphthylalanine unit on PSMA-617. In this work, we investigate the influence of squaric acid moiety on the biological activity of the compound carrying a KuE motif and three typical chelates. The derivatives TRAM.SA.KuE, DOTAGA.SA.KuE and NODAGA.SA.KuE were all synthesized in straightforward organic reactions and purified by HPLC afterward. Different amoun…

Pharmacology010405 organic chemistryOrganic ChemistryBiological activitySquaric acidurologic and male genital diseases01 natural sciencesBiochemistry0104 chemical sciences010404 medicinal & biomolecular chemistrychemistry.chemical_compoundchemistryBiochemistryDrug DiscoveryLNCaPGlutamate carboxypeptidase IIMolecular MedicineMoietyChelationGeneral Pharmacology Toxicology and PharmaceuticsLinkerEx vivoChemMedChem
researchProduct